Price
CHART BY
Historical dividends and forecast
Olympus ADR has so far distributed 0.001157 in 2026. The next dividend will be paid on 24.06.2027
0.0009384
CHART BY
Frequently asked questions
What is Olympus ADR's market capitalization?
The market capitalization of Olympus ADR is $13.60B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Olympus ADR's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Olympus ADR is 27.47. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Olympus ADR?
Olympus ADR's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0.002932. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Olympus ADR's stock?
Currently, 12 analysts cover Olympus ADR's stock, with a consensus target price of $0.0861. Analyst ratings provide insights into the stock's expected performance.
What is Olympus ADR's revenue over the trailing twelve months?
Over the trailing twelve months, Olympus ADR reported a revenue of $43.01M.
What is the EBITDA for Olympus ADR?
Olympus ADR's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $9.65M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Olympus ADR?
Olympus ADR has a free cash flow of $3.06M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Olympus ADR have, and what sector and industry does it belong to?
Olympus ADR employs approximately 28,138 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
Financials
- Market Cap
- $13.60B
- EPS (TTM)
- 0.002932
- P/E ratio (TTM)
- 27.47
- Revenue (TTM)
- $43.01M
- EBITDA (TTM)
- $9.65M
- Free Cashflow (TTM)
- $3.06M
Analyst Ratings
The price target is $0.0861 and the stock is covered by 12 analysts.
Buy
4
Hold
7
Sell
1
Information
Olympus Corp. is a Japan-based global medical technology company that develops and provides innovative solutions for the early detection, diagnosis, and minimally invasive treatment of diseases. It operates through the following segments: Gastrointestinal Solutions and Surgical and Interventional Solution. The company was founded on October 12, 1919 and is headquartered in Tokyo, Japan.
- Employees
- 28,138
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- OLYMY
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet